Addex Therapeutics Ltd (NASDAQ:ADXN)
| 1.15 Delayed Data As of Mar 24 |  +0.09 / +8.49%Today’s Change | 0.55 Today|||52-Week Range 5.45 | +82.51% Year-to-Date |
Latest ADXN News | Press Releases
No recent news for Addex Therapeutics Ltd.
Today’s Trading
| Previous close | 1.06 |
| Today’s open | 1.14 |
| Day’s range | 1.11 - 1.15 |
| Volume | 2,223 |
| Average volume (3 months) | 295,831 |
| Market cap | $14.7M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -475.15% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -23.50% |
| Revenue growth (last year) | -17.10% |
| P/E ratio | NM |
| Price/Sales | 11.14 |
| Price/Book | 0.39 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 27, 2023 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $3.2M |
| Annual profit (last year) | -$16.8M |
| Net profit margin | -523.07% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
